查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2071401

乳房植入市場機會、成長促進因素、產業趨勢分析及2026-2035年預測

Breast Implants Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 129 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年全球乳房植入市場規模預估為29億美元，預計2035年將以7.4%的複合年成長率成長至59億美元。

乳房植入物市場 - IMG1

市場成長主要受美容和重組手術的穩定需求所驅動。人們對美容療程的認知度不斷提高，對美容手術的接受度日益增強，以及專業醫療人員的普及，都促進了已開發國家和新興國家患者群體的擴大。外科技術的不斷進步，改善了手術效果，縮短了恢復時間，提高了患者滿意度，這些都對行業產生了積極影響。隨著治療可及性的不斷提高，越來越多的人開始考慮植入手術，從而支撐了市場的持續擴張。此外，發展中地區醫療基礎設施投資的增加以及成熟市場產品優質化的趨勢，也為長期成長創造了有利條件。植入材料、安全特性和製造流程的技術創新，透過提升產品性能和增強病患信心，進一步強化了市場需求。預計手術量的成長、醫療服務可及性的提高以及產品的持續研發，將使植入產業在整個預測期內保持強勁的成長動能。

市場範圍
開始年份 2025
預測期 2026-2035
起始金額 29億美元
預測金額 59億美元
複合年成長率 7.4%

預計到2025年，矽膠植入將佔據91.4%的市場佔有率，並在2035年之前以7.5%的複合年成長率成長，略高於整體市場成長率。這一市場主導地位反映了數十年來專注於提升植入性能、耐用性和患者療效的產品研發成果。材料成分、結構完整性和臨床表現的持續改進，推動了矽膠植入在美容和重組手術中日益受到青睞。醫療專業人員和患者的廣泛認可，也持續支撐著全球市場的強勁需求。

醫院領域佔據49.48%的市場佔有率，預計2026年至2035年將以7.4%的複合年成長率成長。該領域備受關注的主要原因是重組手術主要集中在醫院進行。醫院擁有先進的手術設施、專業的醫療團隊和完善的患者照護體系，能夠滿足複雜的治療需求。此外，對於需要多學科臨床支援和廣泛術後護理的手術，醫院仍然是首選的治療場所。

預計到2025年，北美乳房植入市佔率將達到35.6%，並在2026年至2035年間以7.8%的複合年成長率成長。該地區市場擴張的促進因素包括：對整形手術的高需求、完善的醫療基礎設施、有利於重組治療的保險報銷政策以及廣泛的專業外科服務。消費者對整形手術的持續關注，以及醫療技術的進步，預計將進一步加速全部區域市場的成長。

目錄

第1章：調查方法

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
  • 影響產業的因素
    • 成長促進因素
      • 隆乳手術數量增加
      • 乳癌發生率增加
      • 植入設計的技術進步
      • 擴大全球整形外科醫師隊伍
    • 產業潛在風險與挑戰
      • 移植手術高成本
      • 手術併發症的風險與安全性問題
    • 機會
      • 亞太和拉丁美洲醫療旅遊的擴張
      • 新興市場重組需求日益成長
  • 成長潛力分析
  • 監理情勢
  • 2025年價格分析
  • 技術與創新展望
    • 最新科技趨勢
    • 新興技術
  • 未來市場趨勢
  • 救贖方案
  • 投資分析
  • 人工智慧和生成式人工智慧對市場的影響
  • 波特的分析
  • PESTLE分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

  • 生理食鹽水植入
  • 矽膠植入

第6章 市場估計與預測：依形狀分類，2022-2035年

  • 圓形的
  • 解剖學

第7章 市場估計與預測：依應用領域分類，2022-2035年

  • 隆乳手術
  • 乳房重建

第8章 市場估算與預測：依質地分類的植入，2022-2035年

  • 光滑的
  • 紋理

第9章 市場估計與預測：依最終用途分類，2022-2035年

  • 醫院
  • 診所
  • 其他最終用戶

第10章 市場估價與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE

第11章：公司簡介

  • AbbVie
  • Establishment Labs
  • Euromi
  • GC Aesthetics
  • Groupe Sebbin
  • Guangzhou Wanhe Plastic Material
  • Hansbiomed
  • IDEAL Implant
  • Laboratoires Arion
  • Mentor Worldwide LLC（Johnson & Johnson）
  • POLYTECH Health & Aesthetics
  • Prayasta 3D Inventions
  • Shanghai Kangning Medical Device
  • Sientra
簡介目錄
Product Code: 2020

The Global Breast Implants Market was valued at USD 2.9 billion in 2025 and is estimated to grow at a CAGR of 7.4% to reach USD 5.9 billion by 2035.

Breast Implants Market - IMG1

Growth in the market is driven by steady demand across both cosmetic enhancement procedures and reconstructive surgical applications. Rising awareness of aesthetic treatments, increasing acceptance of cosmetic surgery, and broader access to specialized healthcare professionals are contributing to a larger patient base across developed and emerging economies. The industry is also benefiting from ongoing advancements in surgical techniques that improve procedural outcomes, reduce recovery periods, and enhance patient satisfaction. As treatment accessibility continues to improve, more individuals are considering breast implant procedures, supporting sustained market expansion. In addition, growing healthcare infrastructure investments in developing regions and continued product premiumization in mature markets are creating favorable conditions for long-term growth. Technological innovations in implant materials, safety features, and manufacturing processes are further strengthening market demand by improving performance and patient confidence. The combination of rising procedure volumes, expanding healthcare access, and continuous product development is expected to maintain positive momentum for the breast implants industry throughout the forecast period.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$2.9 Billion
Forecast Value$5.9 Billion
CAGR7.4%

Silicone implants accounted for 91.4% share in 2025 and are anticipated to grow at a CAGR of 7.5% through 2035, slightly exceeding the overall market growth rate. The segment's dominant position reflects decades of product development focused on enhancing implant performance, durability, and patient outcomes. Continuous improvements in material composition, structural integrity, and clinical performance have strengthened the preference for silicone-based implants across both cosmetic and reconstructive procedures. Their widespread acceptance among healthcare professionals and patients continues to support strong demand across global markets.

The hospitals segment held a 49.48% share, growing at a CAGR of 7.4% during 2026-2035. The segment's prominence is primarily attributed to the high concentration of reconstructive procedures performed within hospital environments, where access to advanced surgical facilities, specialized medical teams, and comprehensive patient care infrastructure supports complex treatment requirements. Hospitals also remain a preferred setting for procedures that require multidisciplinary clinical support and extensive postoperative care.

North America Breast Implants Market accounted for 35.6% share in 2025 and is projected to grow at a CAGR of 7.8% between 2026 and 2035. Regional expansion is supported by high demand for cosmetic procedures, strong healthcare infrastructure, favorable reimbursement frameworks for reconstructive treatments, and broad access to specialized surgical services. Continued consumer interest in aesthetic enhancements and advancements in medical technologies are expected to further strengthen market growth throughout the region.

Key companies operating in the global breast implants market include POLYTECH Health & Aesthetics, Guangzhou Wanhe Plastic Material, Establishment Labs, Hansbiomed, Mentor Worldwide LLC, Sientra, Groupe Sebbin, Euromi, AbbVie, Laboratoires Arion, Shanghai Kangning Medical Device, IDEAL IMPLANT, Prayasta 3D Inventions, and GC Aesthetics. Companies operating in the breast implants market are focusing on product innovation, clinical research, and geographic expansion to strengthen their market position. Manufacturers are investing in advanced implant technologies, enhanced safety features, and improved biomaterials to address evolving patient and surgeon preferences. Strategic collaborations with healthcare providers and aesthetic surgery centers are helping companies expand their customer base and improve product adoption. Many industry participants are also increasing investments in regulatory approvals, post-market surveillance programs, and clinical validation studies to strengthen brand credibility and patient confidence.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Shape trends
    • 2.2.4 Application trends
    • 2.2.5 Implant texture trends
    • 2.2.6 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number of breast augmentation procedures
      • 3.2.1.2 Growing breast cancer incidence
      • 3.2.1.3 Technological advancements in implant design
      • 3.2.1.4 Expanding global plastic surgeon workforce
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of implantation procedure
      • 3.2.2.2 Risk of surgical complications and safety concerns
    • 3.2.3 Opportunities
      • 3.2.3.1 Medical tourism expansion in Asia Pacific and Latin America
      • 3.2.3.2 Rising reconstructive demand in emerging markets
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Pricing analysis, 2025
  • 3.6 Technology and innovation landscape (Driven by Primary Research)
    • 3.6.1 Current technological trends
    • 3.6.2 Emerging technologies
  • 3.7 Future market trends (Driven by Primary Research)
  • 3.8 Reimbursement scenario
  • 3.9 Investment analysis
  • 3.10 Impact of AI & Generative AI on the Market (Driven by Primary Research)
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis (Driven by Primary Research)
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
    • 4.3.5 LAMEA
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Saline implant
  • 5.3 Silicone implant

Chapter 6 Market Estimates and Forecast, By Shape, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Round
  • 6.3 Anatomical

Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Breast augmentation
  • 7.3 Breast reconstruction

Chapter 8 Market Estimates and Forecast, By Implant Texture, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Smooth
  • 8.3 Textured

Chapter 9 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals
  • 9.3 Clinics
  • 9.4 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 MEA
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 AbbVie
  • 11.2 Establishment Labs
  • 11.3 Euromi
  • 11.4 GC Aesthetics
  • 11.5 Groupe Sebbin
  • 11.6 Guangzhou Wanhe Plastic Material
  • 11.7 Hansbiomed
  • 11.8 IDEAL Implant
  • 11.9 Laboratoires Arion
  • 11.10 Mentor Worldwide LLC (Johnson & Johnson)
  • 11.11 POLYTECH Health & Aesthetics
  • 11.12 Prayasta 3D Inventions
  • 11.13 Shanghai Kangning Medical Device
  • 11.14 Sientra